Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the info. PBI was pursuing a west coast manufacturing site. This ought to help jump start their initiative for CBD/THC products.
PBIO has a west coast manufacturing partner? Creme de Cana?
or the makings of a head and shoulders pattern
If you make a bunch of money on SPZI you should try chicken feet. Stop in at a Chinese dim sum restaurant and grab a serving of chicken feet off of one of their food carts rolling around the restaurant. It is very gelatinous (skin and collogen) with little chards of meat around the joints. I think they use star anise as one of the ingredients. It's very tasty and great for hair and nail health. I tried it about three years ago. I was squeamish at first, but once you get pass the idea of eating chicken feet - it's finger lick'n good!
Six more months before we see the light at the end of the tunnel.
Its sniffles season again along with an increase in Covid cases. I went to the mytollovid website to order a bottle and microsoft edge added a $29.90 Tollostudy20 discount. Does anyone know what this discount refers too? I have taken Tollovid since Dec 21 and had three vaccinations. No Covid so far and I'd like to stay that way. I apologize if this question has been asked before. I have been off of this board for a while. I'm also an investor in Todos for some years now and very disappointed with their lack of movement except for a lot of BM.
Anybody home? Looking like the bio availability study will be released soon(?) with their current price/volume activity.
Crickets! This space has gone silent when it should be lighting up! We're at the inflection point of this stock and not a peep from anyone. I'm Very Bullish!
"UST can be used for formulating stable dispersions without the need for any synthetic emulsifier or stabilizers. The knowledge obtained in the present study will facilitate process development of novel clean-label dairy-plant protein dispersions and design the UST equipment."
No! "Short" here,
They continue to sell their UST process and continue raise capital to increase their production capacity for their future sales.
If I wanted to send a man to the moon, I would want a cohort of scientists and engineers. If I wanted to evaluate the effectiveness of UST nano emulsion THC, I would want a cohort of (as you labeled them) potheads and not a group of scientist or engineers.
no SHORT here
Really?
So, the mission to land a man on the moon was not a cohort of like-minded scientist and engineers?
There are two revenue streams they are working on. Tolling and licensing UST. We'll see where this story goes in about a month. Q1 FY23 should be out soon.
Sonomecnanics not the same.......
Customers who would like to produce translucent nanoemulsions of lipophilic (oil-soluble) bio-active compounds, such as cannabis extracts (a.k.a. water-soluble CBD and THC), vitamins, essential oils, terpenes, nutraceuticals and pharmaceuticals, but do not have the capability or desire to develop their own formulations and processing procedures can take advantage of our all-in-one NanoStabilizer®-LT. This proprietary blend of food-grade (GRAS) carrier oils, EMUSIFIERS, and preservatives (all derived from natural sources) is designed to work with ISM laboratory, bench and industrial ultrasonic processors and comes with step-by-step processing instructions. NanoStabilizer®-LT has no taste of its own and makes it possible to easily and quickly produce highly translucent, permanently stable and fully water-compatible nanoemulsions with median droplet sizes in the range of 10 – 50 nanometers.
PBIO opened up UST licensing a week ago. Per the PR it will take 15 to 60 days to close all 5 license agreements. I have not seen any significant dilution of shares over the time I have invested in PBIO. I think the leadership is very responsible in this regard. Yes, there was a 1:30 reverse split several years ago and the recent conversions of debt to equity. I think when PBIO is listed on a major exchange they will issue new shares to fund growth as necessary. What growth company doesn't do this? Stock dilution to fund the company has not been their MO. I see a new name added into the sales/marketing department as a contact for the UST licensing process.
Yes, you are correct. However, the ultrasound method does not produce homogenous droplet size as with UST. Yes, it will produce nano droplet sizes along with larger sizes within the same batch. Batch process means it is not a continuous flow process.
I'm bullish on this company in spite of their so-called incompetence as others have described. Yes, they are a bunch of MIT, Harvard, and Stanford geeks who developed a new mousetrap. Actually, three new mouse traps. One of which they purchased from another company. However, I believe there is significant commercial interest in the UST platform. I have personally sampled UST processed CBD sourced from two different companies. It is transparent and it is water soluble. It dilutes instantaneously in water. The range of applications for this process is TBD, but already they are simultaneously gaining traction in several markets. Cash strapped, yes. However, the THC/CBD industry have lots of free flowing green cash. Installing UST equipment in legal states makes great sense by getting around Federal interstate trafficking regulations.
Nice to see other contributors on this board.
The company maintained very low float for a very long time and accumulated debt. I think it's a good move to convert debt into equity. The last conversion rate was very attractive for shareholders at $2.50/shr. Time to move the company onto the big board. In order to do that debt has to be reduced and increase revenue. Revenue will be stalled until they get their new facility at Artisan up and running. Cross our fingers.
I'm thinking the 10M loan/equity conversion is being sold off to fund this tolling station/manufacturing relationship. Otherwise, where is the $ coming from to move forward with this major PBIO strategic move? Sell off 1M shares/keep 4M shares. 4M shares rise to $5.00/shr. Who is the mystery donor? It would have to be someone within the inner circle of PBIO if my hunch is correct.
Nice way to end Q4 22 with relevant UST derived revenues and stocking up on inventory for future PBI Agrichem sales. There must be some eminent POs in the Agrichem sales pipeline. I hope it won't take 3 1/2 months to see Q1 23 earnings, but an all time record Q revenue in the company's history is a good way to start the new year!
Nice! PBIO showing off their pressure processing in the pharma space. All three of their platforms apply, but UST will be a game changer for PBIO and pharma. Royalties for each dose created from PBIO processing. Great to see them finally trying to build relationships into this market. They must have a few extra marketing nickels to spend for this exposure. I'm hoping to see stellar FY22 and Q4 22 financials on Monday. Thanks for posting Louied91.
PBIO FY22 is due out on the 17th as well.
We should see the long awaited FY22 and Q4 22 UST related revenues by next Monday.
PRESSURE BIOSCIENCES, INC. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report”) by the March 31, 2023 filing date applicable to smaller reporting companies due to a delay experienced by the Registrant in completing its financial statements and other disclosures in the Annual Report. As a result, the Registrant is still in the process of compiling required information to complete the Annual Report and its independent registered public accounting firm requires additional time to complete its review of the financial statements for the period ended December 31, 2022 to be incorporated in the Annual Report. The Registrant anticipates that it will file the Annual Report no later than April 17, 2023 (the first business day after the fifteenth calendar day following the prescribed filing date
Extracted from a press released today:
Mr. Richard T. Schumacher, President and CEO of PBIO, commented: "The PBIO Team is delighted with the strong recent progress in multiple aspects of our business. We are redesigning our production facilities, adding to our team, strengthening our core capabilities, filing additional UltraShear patents, building instrument inventories, and expanding our list of existing and prospective 2023 customers. We are engaging deeper into building strong strategic partnerships with key companies and individuals, including several billion-dollar companies who are global best-in-class players in priority markets targeted for explosive growth. In addition, we have begun forging stronger relationships with
multiple strategic and retail investors." (EMGE?)
My guess is 10M will be from PBIO FY23 forecast.
8:15 am ET January 27, 2023 (Accesswire) Print
NBA Legend Isiah Thomas Leads Effort to Innovate and Deliver Next Generation Sports Drinks
SOUTH EASTON, MA / ACCESSWIRE / January 27, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, and One World Products, Inc. (OTCQB: OWPC) ("OWPC"), the largest Black-controlled, fully-licensed hemp and cannabis producer in Colombia, today announced they have entered into an active collaboration agreement ("Agreement") under which the two companies will combine their strong, symbiotic capabilities to develop an innovative line of next generation sports performance/recovery drinks.
The Sports Performance/Recovery Drink Market encompasses live sports performance optimization, rapid and effective full recovery post-performance, and health and wellness areas - including immune health and antioxidant benefits. Fast delivery and uptake of therapeutic and nutritional ingredients must be made effective for the many oil-soluble active ingredients used in sports drinks. This is where PBIO's revolutionary UltraShear™ nanoemulsions platform technology is already demonstrating game-changing results across multiple major consumer market applications. The "Recovery" market has also been supported by increasing numbers of consumers who consider themselves "non-athletes" joining in the sports drink craze. Data from IRI put sales of sports/performance beverages at about $9.5 billion for 2021 (sports drink market 2021).
Isiah Thomas, Chairman and CEO of OWPC, highlighted: "This revolutionary new line of sports performance/recovery drinks will contain OWPC's premium quality CBD that has been processed into a highly stable and extremely bioavailable nanoemulsion by PBIO's patented UltraShear technology platform. This next generation CBD-nanoemulsion beverage is being designed for fast reduction of inflammation and pain, improved recovery time, and enhanced overall performance - all to be achieved quicker than any competing drink on the market today. It is being formulated to help athletes push through the tough moments of a workout or competition, and to recover more quickly afterward. In professional and even amateur sports, athletes understand the criticality of peak performance and recovery."
Mr. Thomas continued: "OWPC has been a highly sought after choice for the development of new and premium technologies for delivery of hemp and cannabis-derived products. I am excited that we have an opportunity to pair our premium quality CBD product with PBIO's proprietary, cutting-edge nanoemulsification technology to deliver a uniquely-innovative and effective product to market that we believe will offer unmatched rapid absorption and full dosing of hard-to-deliver oil-soluble ingredients - to achieve game-changing performance."
Richard T. Schumacher, President and CEO of PBIO, expanded: "Partnering with Isiah and his exceptional team at OWPC is an extraordinary opportunity for PBIO to accelerate the visibility and impact of our revolutionary UltraShear nanoemulsions platform technology. Isiah is a world-renowned figure in the world of sports and more broadly as a role model in Black-owned business leadership, and it is a privilege for our companies to team up! OWPC has become a leading producer of the highest quality and sustainably sourced hemp-derived CBD in Colombia, and is closely partnered with their government and indigenous populations. Teamed with PBIO's best-in-class nanoemulsions processing, OWPC is uniquely positioned to deliver these solutions and drive rapid recognition and acceptance across the worlds of professional and amateur sports. This is going to be exciting and, we believe, very successful!
Check out PBIO press release. It says Isiah Thomas.
1:500 isn't strong enough for listing under current SP.
1000:1 R/S
For every seller there is a buyer.
Did EMGE report PBIO Q4 revenues? 400K
Hmmm... Nanostetics, a possible acquisition to complement the PBIO acquisition? PBIO needs a tolling station to process oil based active ingredients such as CBD, THC, Rogane, Astaxanthin, etc.... Yes, a clean room is a must! A nano company needed for another nano company.
Why isn't there any conversation regarding PBIO? Didn't EMGE acquire PBIO back in August? Who knows of a company that can mix oil with water? The possibilities are worth billions!
TOMDF Botanical should team with PBIO. Water soluble nano emulsion hemp products.
80 reviews on Amazon.
I've taken Tollovid since December 2021. No Covid for me. Back in October I sent a friend in Italy two bottles. He recently tested positive for Covid. I recommended 6 - 12 capsules a day. He thought it was too many so he took 3 a day. No more Covid. I'm a believer.
Show me
Should see tangible news the day before or on the day of presentation.
My hunch (which is also an educated guess) is an EUA out of Israel. Not sure if an EUA is even required? Todos Botanical fell out of the sky which gave me a WTFo pause. Todos pivoting to CBD???? Nah, it's to provide an in-house production capacity for Tollovid/ir so not to be limited by cost, scheduling, and quantity of a third party manufacturer. It would be difficult for any company to respond to a Government contract with an IDIQ requirement. GC mentioned (from the many twitter posts) the possibility of an Israel contract for Israeli healthcare workers - Tollovid. Nerd Hemp was just the beginning.
My hunch............
MB
My hunch is telling me there is a quiet before the storm. News blackout then BAM! We'll see what happens next week.